🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› China
Clinical trial register · China

Studies with a Chinese investigative site

Every study on the ClinicalTrials.gov registry that lists a site in China and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 19052 matching records held by the registry are in this view. Synced 22 Sep 2026, 11:10 UTC
19052
Studies in scope
all four open statuses
11786
Recruiting now
open to new participants
2009
Lead sponsors
across recruiting studies
Top sites
Beijing 5484 Shanghai 3827 Guangzhou 3318 Hangzhou 1812 Wuhan 1343
Narrow the register
Recruitment status
Phase
Lead sponsor
Sun Yat-sen University490 Fudan University472 Second Affiliated Hospital, Zhejiang University, School of Medicine404 Peking Union Medical College Hospital282 Ruijin Hospital281
Site location
Beijing5484 Shanghai3827 Guangzhou3318 Hangzhou1812 Wuhan1343
All 613 locations
Target enrolment
to
19052 of 19052 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Chinese sites
Start
Recruiting
Pembrolizumab Plus Neoadjuvant Chemotherapy vs. Neoadjuvant Chemoradiotherapy for Locally Advanced ESCC (KEYSTONE-002)
NCT04807673Esophageal Squamous Cell Carcinoma
Tianjin Medical University Cancer Institute and Hospital
Phase 3
342
Tianjin
2021-12-01
Recruiting
Neoadjuvant FOLFOXIRI Versus Immediate Surgery for Stage II and III Colon Cancers
NCT05194878Colon Cancer Stage II, Colon Cancer Stage III
Sun Yat-sen University
Phase 3
840
Guangzhou
2021-12-01
Active, closed
A Study of Pimitespib in Combination With Imatinib in Patients With GIST (CHAPTER-GIST-101)
NCT05245968Gastrointestinal Stromal Tumors
Taiho Pharmaceutical Co., Ltd.
Phase 1
78
Beijing, Shanghai
2021-12-01
Recruiting
Ruxolitinib and Chidamide Intensified Bu/CY Conditioning Regimen
NCT05088226Peripheral Blood Stem Cell Transplantation
Chinese PLA General Hospital
Phase 2
50
Beijing
2021-12-01
Recruiting
Mental Health During the Whole Life Cycle of Community Patients With Schizophrenia
NCT05159349Schizophrenia
Shanghai Mental Health Center
Observational
1,200
Shanghai
2021-12-01
Not yet open
Exosome-based Nanoplatform for Ldlr mRNA Delivery in FH
NCT05043181Familial Hypercholesterolemia
Tang-Du Hospital
Phase 1
30
Xi'an
2021-12
Not yet open
Cardiovascular Diseases and Diabetes Prevention Programme in Metabolic Syndrome (CDPP)
NCT05105321Metabolic Syndrome
Tang Yida
Phase 4
5,200
Beijing
2021-12
By invitation
Observation on Obesity Undergoing XOWI
NCT05122936Obesity, Traditional Chinese Medicine
Feng Tao
Observational
500
Shanghai
2021-11-30
Active, closed
The Study on the Safety and Efficacy of the G-iliac Iliac Bifurcation Stent Graft System
NCT06660927Common Iliac Artery Aneurysm
Lifetech Scientific (Shenzhen) Co., Ltd.
Not applicable
500
Beijing
2021-11-30
Active, closed
PREvention of Intrauterine Adhesion After Adhesiolysis With Novel Tri-block deGradable Polymer Film.
NCT04963179Asherman Syndrome, Intrauterine Adhesion
Womed
Not applicable
160
Guangzhou, Hangzhou, Shanghai
2021-11-29
Recruiting
A Study of BL-B01D1 in Patients With Locally Advanced or Metastatic Solid Tumor
NCT05194982Locally Advanced or Metastatic Solid Tumor
Sichuan Baili Pharmaceutical Co., Ltd.
Phase 1
570
Chongqing, Guangzhou, Wuhan, Changsha, Shanghai, Taiyuan
2021-11-29
Recruiting
OTSC vs. Angiographic Embolization in Patients With Refractory Non-variceal Upper Gastrointestinal Bleeding
NCT04902248Upper Gastrointestinal Bleeding
Chinese University of Hong Kong
Not applicable
236
Beijing, Nanchang, Chengdu
2021-11-27
Recruiting
A Prospective, Open, Multicenter Single-arm Clinical Studie of Docetaxel, Carboplatin Combined With Inetetamab and Pyrotinib in the Treatment of Local-advanced HER2-positive Breast Cancer
NCT06234137Breast Neoplasm Female
Wang Ouchen
Not applicable
154
Wenzhou
2021-11-27
Active, closed
A Study of GNC-035, a Tetra-specific Antibody, in Participants With Locally Advanced or Metastatic Breast Cancer
NCT05160545Breast Cancer
Sichuan Baili Pharmaceutical Co., Ltd.
Phase 1
36
Bengbu, Dongguan, Guangzhou, Changsha, Chengdu
2021-11-26
Active, closed
Evaluation of the Tolerance, Safety, Pharmacokinetics, Pharmacodynamics, and Efficacy of MIL62 Injection for Treating Lupus Nephritis
NCT07044115Lupus Nephritis
Beijing Mabworks Biotech Co., Ltd.
Phase 1/2
41
Beijing
2021-11-26
Recruiting
Multicomponent Prehabilitation and Outcomes in Elderly Patients With Frailty
NCT04715581Old Age; Debility, Digestive Cancer, Surgery, Preoperative Rehabilitation
Peking University First Hospital
Not applicable
540
Beijing
2021-11-25
Recruiting
Multicenter Study on Postoperative Urinary and Sexual Function During Laparoscopic Functional Total Mesorectum Excision
NCT05049317Rectal Cancer
Renmin Hospital of Wuhan University
Not applicable
88
Wuhan
2021-11-24
Recruiting
The Impact of Immune Cell Changes During the Perioperative Period on the Prognosis of Patients With Colorectal Cancer
NCT05015296Colorectal Cancer
Beijing Friendship Hospital
Observational
7,000
Beijing
2021-11-23
Active, closed
Study of Inclisiran to Prevent Cardiovascular (CV) Events in Participants With Established Cardiovascular Disease
NCT05030428Atherosclerotic Cardiovascular Disease
Novartis Pharmaceuticals
Phase 3
17,004
Beijing, Foshan, Guangzhou, Nanning, Harbin, Jingzhou, Wuhan, Changsha
2021-11-23
Recruiting
Effect of Theta-Burst Transcranial Magnetic Stimulation (TBS) for Freezing of Gait
NCT05192759Transcranial Magnetic Stimulation, Freezing of Gait
Anhui Medical University
Not applicable
40
Hefei
2021-11-22
Recruiting
Therapy Evaluation in Patients With Minor Stroke and Large Vessel Occlusion
NCT06633809Stroke, Acute, Cerebrovascular Disorders, Brain Diseases, Central Nervous System Diseases
Sir Run Run Shaw Hospital
Observational
200
Hangzhou
2021-11-22
Recruiting
Ruijin Neurobank of Alzheimer's Disease and Dementia
NCT05623124Dementia
Ruijin Hospital
Observational
400
Shanghai
2021-11-22
Active, closed
TACS Intervention for Methamphetamine Addiction
NCT06288997Methamphetamine Use Disorder
Shanghai Mental Health Center
Not applicable
70
Beijing, Wuhan, Nanjing, Suzhou, Deyang
2021-11-21
Active, closed
JMT101 Combined With Osimertinib in Patients With Stage Ⅲb-Ⅳ Non-small Cell Lung Cancer (NSCLC) Characterized by Epithermal Growth Factor Receptor (EGFR) Common Mutations
NCT06391944Local Advanced or Metastatic NSCLC, Harboring EGFR Common Mutation
Shanghai JMT-Bio Inc.
Phase 2
161
Beijing
2021-11-21
Recruiting
Research on Key Interventional Technologies for Controlling the Epidemic in High-prevalence Areas of Tuberculosis in Guangxi, China
NCT06702774Tuberculosis (TB)
University of Toronto
Not applicable
72,000
Nanning
2021-11-20
Recruiting
A Study of GC101 TIL in Advanced Breast Cancer (10hospital)
NCT05142475Breast Cancer, Treatment Side Effects, Advanced Breast Cancer, Effects of Immunotherapy
Shanghai Juncell Therapeutics
Phase EARLY_PHASE1
50
Shanghai
2021-11-19
Active, closed
A Study of LP-128 Capsules in Healthy Subjects
NCT05130567Chronic Hepatitis b
Guangzhou Lupeng Pharmaceutical Company LTD.
Phase 1
104
Guangzhou
2021-11-19
Active, closed
Efficacy and Safety of Selumetinib in Adults With NF1 Who Have Symptomatic, Inoperable Plexiform Neurofibromas
NCT04924608Neurofibromatosis 1, Plexiform Neurofibroma (PN)
AstraZeneca
Phase 3
145
Beijing, Guangzhou, Shenyang
2021-11-19
Recruiting
Assessing an Oral EGFR Inhibitor, DZD9008 in Patients With Advanced Non-small Cell Lung Cancer(NSCLC) With EGFR Mutations (WU-KONG15)
NCT05559645Non Small Cell Lung Cancer
Peking Union Medical College Hospital
Not applicable
180
Beijing
2021-11-18
Recruiting
Pemetrexed and Carboplatin With or Without Anlotinib Hydrochloride for Osimertinib-resistant Non-squamous NSCLC
NCT04136535NSCLC Stage IV
Fudan University
Phase 2
105
Shenzhen
2021-11-18
Active, closed
Pediatric Spinal Muscular Atrophy (SMA) China Registry
NCT05042921Muscular Atrophy, Spinal
Biogen
Observational
600
Hefei, Beijing, Chongqing, Fuzhou, Xiamen, Guangzhou, Shenzhen, Nanning
2021-11-18
Recruiting
CD 70 CAR T for Patients With CD70 Positive Malignant Hematologic Diseases
NCT04662294Acute Myeloid Leukemia, Non-hodgkin's Lymphoma, Multiple Myeloma
Zhejiang University
Phase EARLY_PHASE1
108
Hangzhou
2021-11-18
Recruiting
Head-to-head Comparison of Diagnosis Value of Pulmonary Fibrosis on 68Ga-FAPI-04 and 18F-FDG PET-CT
NCT05121779Pulmonary Fibrosis
Peking Union Medical College Hospital
Phase 1
80
Beijing
2021-11-18
Recruiting
Open-Label Extension Study of Marstacimab in Hemophilia Participants With or Without Inhibitors
NCT05145127Hemophilia A, Hemophilia B
Pfizer
Phase 3
245
Guangzhou, Guiyang, Wuhan, Nanchang, Tianjin, Beijing
2021-11-17
Active, closed
A Study Evaluating the Efficacy, Safety, Pharmacokinetics and Pharmacodynamics of Crovalimab in Pediatric Participants With Atypical Hemolytic Uremic Syndrome (aHUS)
NCT04958265Atypical Hemolytic Uremic Syndrome
Hoffmann-La Roche
Phase 3
41
Beijing, Hangzhou
2021-11-17
Active, closed
A Phase 3 Study to Evaluate the Safety and Efficacy of Efgartigimod PH20 Subcutaneous in Adult Patients With Primary Immune Thrombocytopenia
NCT04812925Primary Immune Thrombocytopenia
argenx
Phase 3
173
Beijing, Bengbu, Huizhou, Shenzhen, Tianjin, Wuhan, Wuxi, Zhengzhou
2021-11-17
Active, closed
A Study of Amivantamab and Lazertinib in Combination With Platinum-Based Chemotherapy Compared With Platinum-Based Chemotherapy in Patients With Epidermal Growth Factor Receptor (EGFR)-Mutated Locally Advanced or Metastatic Non- Small Cell Lung Cancer After Osimertinib Failure
NCT04988295Carcinoma, Non-Small-Cell Lung
Janssen Research & Development, LLC
Phase 3
776
Beijing, Changsha, Chengdu, Chongqing, Guangzhou, Hangzhou, Harbin, Huizhou
2021-11-17
Active, closed
A Study of XZP-3287 in Combination With Fulvestrant in Patients With Advanced Breast Cancer
NCT05077449Advanced Breast Cancer
Xuanzhu Biopharmaceutical Co., Ltd.
Phase 3
300
Beijing
2021-11-16
Active, closed
A Phase I/II Study of CM355 in Patients With Relapsed or Refractory B-Cell Non-Hodgkin's Lymphoma (B-NHL)
NCT05210868Hematoma
Beijing InnoCare Pharma Tech Co., Ltd.
Phase 1/2
184
Beijing
2021-11-16
Recruiting
Phase Ib/II Trial of Envafolimab Plus Lenvatinib for Subjects With Solid Tumors
NCT05024214Solid Tumors, Non-small Cell Lung Cancer, Renal Cell Carcinoma, Hepatocellular Carcinoma
3D Medicines (Sichuan) Co., Ltd.
Phase 1/2
170
Bengbu, Beijing, Fuzhou, Xiamen, Dongguan, Guangzhou, Zhuhai, Haerbin
2021-11-15
Active, closed
Intraoperative Rapid Diagnosis of Glioma Based on Fusion of Magnetic Resonance and Ultrasound Imaging
NCT05656053Glioma, Malignant, Computer-Assisted Surgery
Mingge LLC
Observational
30
Shanghai
2021-11-15
Active, closed
Study of Efficacy and Safety of Dabrafenib in Combination With Trametinib in Previously Treated Patients With Metastatic, Radio-active Iodine Refractory BRAF V600E Mutation Positive Differentiated Thyroid Cancer
NCT04940052Differentiated Thyroid Cancer (DTC)
Novartis Pharmaceuticals
Phase 3
153
Fuzhou, Zhengzhou, Wuhan, Changsha, Nanjing, Xuzhou, Changchun, Chengdu
2021-11-15
Recruiting
Westlake Longevity Cohort
NCT05256251Aging
Westlake University
Observational
1,500
Lishui
2021-11-15
Active, closed
Methotrexate Combined With Immunotherapy During Radiotherapy for Solid Tumors
NCT05522582Solid Tumors
Yancheng First People's Hospital
Phase 2
50
Yancheng
2021-11-15
Recruiting
ALK Tyrosine Kinase Inhibitors in ALK-rearranged Advanced Squamous Cell Carcinoma
NCT05014464Non-small Cell Lung Cancer
Hunan Province Tumor Hospital
Phase 2
90
Changsha
2021-11-13
Recruiting
Safety and Efficacy of EX103 in Subjects with Relapsed/Refractory CD20-Positive Non-Hodgkin Lymphoma
NCT06021678CD20-positive Non-Hodgkin Lymphoma
Guangzhou Excelmab Inc.
Phase 1/2
415
Zhengzhou, Jinan, Shanghai, Tianjin
2021-11-12
Recruiting
Safety and Efficacy of a Multi-branched Thoracoabdominal Stent Graft System for Thoracoabdominal Aortic Aneurysm.
NCT05054985Thoracoabdominal Aortic Aneurysms
Lifetech Scientific (Shenzhen) Co., Ltd.
Not applicable
73
Beijing
2021-11-12
Not yet open
Clinical Study on the Efficacy of Single-port Inflatable Mediastinoscopy Combined With Laparoscopic-assisted Small Incision Surgery and Thoracoscopy Combined With Laparoscopic Surgery for Radical Esophagectomy
NCT05105945Esophageal Cancer
Fifth Affiliated Hospital, Sun Yat-Sen University
Not applicable
1,164
Zhuhai
2021-11-11
Active, closed
Camrelizumab in Combination With Radiotherapy for Neoadjuvant Esophageal Carcinoma.
NCT05176002Esophageal Neoplasm, Immunotherapy, Radiotherapy
Fujian Medical University Union Hospital
Phase 1/2
25
Fuzhou
2021-11-10
Recruiting
The Impact of Atrial Pressure Change Before and After Combined Procedure
NCT05106270Atrial Fibrillation, Heart Failure
Shanghai 10th People's Hospital
Observational
100
Shanghai
2021-11-10
Recruiting
Effects of Music Therapy on Psychological States Among Cancer Patients Undergoing MRI Scans and a Relevant Mediator
NCT06282887Psycho-Oncology
Guangzhou Concord Cancer Center
Not applicable
80
Guangzhou
2021-11-09
Active, closed
A Study to Evaluate the Efficacy and Safety of ONO-4538 in Combination With Ipilimumab and Chemotherapy in Chemotherapy-naïve Participants With HER2-negative Unresectable Advanced or Recurrent Gastric Cancer (Including Esophagogastric Junction Cancer)
NCT05144854Gastric Cancer
Ono Pharmaceutical Co., Ltd.
Phase 3
626
2021-11-05
Recruiting
Immune Score Based Radiomics in Nasopharyngeal Carcinoma
NCT05126160Nasopharyngeal Carcinoma
Zhejiang Cancer Hospital
Observational
494
Wuhan, Ningbo, Wenzhou, Hangzhou
2021-11-05
Recruiting
Targeted Optical Biopsy for Local Rectal Scars in Rectal Cancer Patients After Neoadjuvant Chemoradiotherapy
NCT05316103Rectal Cancer
Nanfang Hospital, Southern Medical University
Not applicable
68
Guangzhou
2021-11-04
Active, closed
SG301 Safety Study in Subjects With Relapsed or Refractory Multiple Myeloma and Other Hematological Malignancies
NCT04684108Relapsed or Refractory Multiple Myeloma, Hematological Malignancy
Hangzhou Sumgen Biotech Co., Ltd.
Phase 1
61
Bengbu, Beijing, Shenzhen, Shijiazhuang, Zhengzhou, Wuhan, Xiangyang, Wuxi
2021-11-04
Recruiting
Clinical Trial Protocol for the Combined Use of VAG in the Treatment of ND-AML
NCT06536010Acute Myeloid Leukemia
Yang Xiaotian
Not applicable
50
Huai'an
2021-11-03
Recruiting
A Study of AK109 Combined With AK104 in Patients With Advanced Solid Tumors
NCT05142423Advanced Solid Tumor
Akeso
Phase 1/2
198
Hangzhou
2021-11-03
Recruiting
A Study Evaluating the Value of 68Ga-Pentixafor PET Imaging in the Staging of Hematological Tumor, and Comparing It with 18F-FDG PET/CT Imaging
NCT06834412Hematological Malignancies
Xijing Hospital
Not applicable
120
Xi'an
2021-11-03
Recruiting
Anticoagulant Plus Antiplatelet Therapy Following Iliac Vein Stenting
NCT04694248Deep Vein Thrombosis, Iliac Vein Thrombosis, Iliac Vein Obstruction, Iliac Vein Stenosis
First Affiliated Hospital of Zhejiang University
Not applicable
172
Hangzhou
2021-11-03
Active, closed
Study Comparing Blinatumomab Alternating With Low-intensity Chemotherapy Versus Standard of Care Chemotherapy for Older Adults With Newly Diagnosed Philadelphia-negative B-cell Precursor Acute Lymphoblastic Leukemia
NCT04994717Newly Diagnosed Philadelphia (Ph)-Negative B-cell Precursor Acute Lymphoblastic Leukemia (ALL)
Amgen
Phase 3
303
2021-11-02
Recruiting
First-in-Human Evaluation of an Astrocytic Glutamate Transporter (EAAT2) PET Tracer in Dementia
NCT05374278Alzheimer Disease, Frontotemporal Dementia, Dementia
David Wilson
Phase 1/2
102
2021-11-02
Recruiting
Comparison of MBR + Suture Tape, MBR, and Anatomic Reconstruction for CLAI in GJL Cases: A Prospective Cohort Study
NCT05698446Ankle Sprains, Hypermobility Syndrome
Peking University Third Hospital
Observational
114
Beijing
2021-11-01
Recruiting
Triplex Checkpoint Inhibitors Therapy for Advanced Solid Tumors
NCT05187338Lung Cancer, Liver Cancer, Colorectal Cancer, Pancreas Cancer
Second Affiliated Hospital of Guangzhou Medical University
Phase 1/2
100
Guangzhou
2021-11-01
Active, closed
1-month DAPT Plus 5-month Ticagrelor Monotherapy Versus 12-month DAPT in Patients With Drug-coated Balloon
NCT04971356Antiplatelet Drug, Acute Coronary Syndrome, Angioplasty, Balloon
Xijing Hospital
Not applicable
1,948
Xi'an
2021-11-01
Recruiting
The Osteoarticular Manifestations in Patients With Gitelman Syndrome
NCT06922370Gitelman Syndrome, CPPD - Calcium Pyrophosphate Deposition Disease
Second Affiliated Hospital, Zhejiang University, School of Medicine
Observational
120
Hangzhou
2021-11-01
Recruiting
Comparison of Posterior Continuous Curvilinear Capsulorhexis With or Without Anterior Vitrectomy
NCT05136209Congenital Cataract
Sun Yat-sen University
Not applicable
50
Guangzhou
2021-11-01
Recruiting
The Effects of Hydroxychloroquine in Patients with Inflammatory Cardiomyopathy
NCT05961202Inflammatory Cardiomyopathy, Myocarditis
Tongji Hospital
Phase 2/3
200
Wuhan
2021-11-01
Recruiting
Cohort Study on Treatment of Cardiovascular Diseases With Traditional Chinese Medicine
NCT05309343Cardiovascular Diseases
Tianjin University of Traditional Chinese Medicine
Observational
20,000
Tianjin
2021-11-01
Recruiting
Early Intervention of Prodromal Schizophrenia Using an NMDA Enhancer
NCT05052853Prodromal Schizophrenia
China Medical University Hospital
Phase 2
48
2021-11-01
Recruiting
Axillary Lymph Node Treatment Guided by Naocarbon Tracing After Neoadjuvant Chemotherapy
NCT05241119Breast Cancer
Shengjing Hospital
Not applicable
100
Shenyang
2021-11-01
Recruiting
Multi-parametric MRI and Dual-energy CT in Patients of Gastric Cancer
NCT05508126Gastric Cancer Stage
The First Affiliated Hospital with Nanjing Medical University
Observational
222
Nanjing
2021-11-01
Recruiting
Top Down Versus Step up in Pediatric Ulcerative Colitis
NCT04999228Ulcerative Colitis, Infliximab, Children
Children's Hospital of Fudan University
Phase 4
40
Shanghai
2021-11-01
Recruiting
Chinese Longitudinal and Systematic Study of Bioplar Disorder
NCT05480150Major Depressive Disorder, Bipolar Disorder, Mixed, Affective; Disorder, Organic
First Affiliated Hospital of Zhejiang University
Not applicable
10,000
Hangzhou
2021-11-01
Recruiting
Triage of Patients With Acute Ischemic Stroke Due to Large Vessel Occlusions-2
NCT05659160Stroke, Acute Ischemic, Endovascular Procedures, Large Vessel Occlusion
Tianjin Huanhu Hospital
Observational
5,000
Tianjin
2021-11-01
Recruiting
Comparison of Tofacitinib and Methotrexate in Takayasu's Arteritis
NCT05102448Takayasu Arteritis
Shanghai Zhongshan Hospital
Phase 4
76
Shanghai
2021-11-01
Recruiting
Optimal Non-invasive Brain Stimulation for Peripheral Vision
NCT04846140Glaucoma
The Hong Kong Polytechnic University
Not applicable
40
Hong Kong
2021-11-01
Recruiting
Cryoablation Combined with Sintilimab Plus Lenvatinib in Previously Treated Unresectable Liver Metastasis from Solid Tumors
NCT05098847Liver Metastasis
Fudan University
Phase 2
25
Shanghai
2021-10-29
Active, closed
A Study of NINLARO® in Chinese Adults With Multiple Myeloma
NCT05013190Multiple Myeloma
Takeda
Observational
72
Hefei, Beijing, Zhengzhou, Hohhot, Suzhou, Nanchang, Shenyang, Qingdao
2021-10-29
Active, closed
A Study to Investigate the Efficacy and Safety of Trastuzumab Deruxtecan as the First Treatment Option for Unresectable, Locally Advanced/Metastatic Non-Small Cell Lung Cancer With HER2 Mutations
NCT05048797Locally Advanced or Metastatic Non-Small Cell Lung Cancer
AstraZeneca
Phase 3
454
Beijing, Changchun, Changsha, Chengdu, Fuzhou, Guangzhou, Hangzhou, Jinan
2021-10-28
Active, closed
Savolitinib Plus Durvalumab Versus Sunitinib and Durvalumab Monotherapy in MET-Driven, Unresectable and Locally Advanced or Metastatic PRCC
NCT05043090Papillary Renal Cell Carcinoma
AstraZeneca
Phase 3
148
Beijing, Changsha, Chongqing, Harbin, Jinan, Nanjing, Shanghai, Shenyang
2021-10-28
Recruiting
Use of Determine Learning-based Cardiodynamicsgram (CDG) for Rapid and Precise Stratification of Chest Pain in Emergency Department
NCT06669884Chest Pain, Acute Coronary Syndrome
Qilu Hospital of Shandong University
Observational
8,000
Jinan
2021-10-28
Active, closed
A Study Evaluating the Efficacy and Safety of Mosunetuzumab in Combination With Lenalidomide in Comparison to Rituximab in Combination With Lenalidomide With a US Extension of Mosunetuzumab in Combination With Lenalidomide in Participants With Follicular Lymphoma
NCT04712097Relapsed or Refractory Follicular Lymphoma
Hoffmann-La Roche
Phase 3
478
Beijing, Changchun, Guangzhou, Harbin, Nanchang, Nanjing, Shanghai, Tianjin
2021-10-27
Active, closed
A Study to Evaluate Pembrolizumab Plus Lenvatinib in PD-L1 Positive TKI Resistant NSCLC Patients
NCT05078931NSCLC
Shanghai Chest Hospital
Phase 2
35
Shanghai
2021-10-27
Active, closed
A Phase 1 Study of HRS8807 Monotherapy and in Combination With SHR6390 in Subjects With ER-Positive, HER2-Negative Metastatic or Locally Advanced Breast Cancer
NCT04993430ER-Positive, HER2-Negative Breast Cancer
Shanghai Hengrui Pharmaceutical Co., Ltd.
Phase 1
46
Shanghai
2021-10-26
Recruiting
A Phase I/IIa Study of AL8326 Combined With Toripalimab in the Treatment of Advanced Solid Tumors.
NCT07392736Solid Tumor
Advenchen Laboratories, LLC
Phase 1/2
228
Beijing, Hunan, Fuzhou, Shantou, Shaoguan, Guilin, Liuzhou, Nanning
2021-10-26
Active, closed
The Registry of Genetic Alterations of Taiwan Biliary Tract Cancer
NCT05036486Biliary Tract Cancer (BTC)
National Health Research Institutes, Taiwan
Observational
480
2021-10-25
Recruiting
A Study of Icotinib With Chemotherapy as Neoadjuvant Therapy for Patients With EGFRm Positive Resectable Non-Small Cell Lung Cancer
NCT05104788Non-Small Cell Lung Cancer
Peking University Cancer Hospital & Institute
Phase 2
27
Beijing
2021-10-25
Recruiting
First in Human Study of BAY2927088 in Participants Who Have Advanced Non-small Cell Lung Cancer (NSCLC) With Mutations in the Genes of Epidermal Growth Factor Receptor (EGFR) and/or Human Epidermal Growth Factor Receptor 2 (HER2)
NCT05099172Advanced Non-small Cell Lung Cancer, EGFR Mutation, HER2 Mutation
Bayer
Phase 1/2
400
Beijing, Fuzhou, Harbin, Wuhan, Changsha, Nanjing, Taizhou, Jinan
2021-10-25
Active, closed
Trastuzumab Deruxtecan (T-DXd) Alone or in Sequence With THP, Versus Standard Treatment (ddAC-THP), in HER2-positive Early Breast Cancer
NCT05113251Breast Neoplasms, Breast Cancer, HER2-positive Early Breast Cancer
AstraZeneca
Phase 3
927
Beijing, Changsha, Chongqing, Guangzhou, Kunming, Nanning, Qingdao, Shanghai
2021-10-25
Recruiting
Treatment and Prognosis of Patients With Chronic HBV Infection
NCT05392387Hepatitis B Virus Infection
Xiangya Hospital of Central South University
Observational
500
Changsha
2021-10-25
Active, closed
A Study of FDA018-ADC in Patients With Advanced Solid Tumors
NCT05174637Advanced/ Metastatic Solid Tumors
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd.
Phase 1
78
Shanghai
2021-10-22
Active, closed
A Phase 3 Study of BIBP Diphtheria, Tetanus and Acellular Pertussis (Three Components) Combined Vaccine, Adsorbed
NCT05091619Whooping Cough, Diphtheria, Tetanus
China National Biotec Group Company Limited
Phase 3
2,898
Anyang, Jiaozuo, Luohe, Xinxiang
2021-10-22
Active, closed
A Study Evaluating the Efficacy, Safety, Pharmacokinetics and Pharmacodynamics of Crovalimab in Adult and Adolescent Participants With Atypical Hemolytic Uremic Syndrome (aHUS)
NCT04861259Atypical Hemolytic Uremic Syndrome
Hoffmann-La Roche
Phase 3
83
Beijing
2021-10-22
Recruiting
Mutant KRAS G12V-specific TCR Transduced T Cell Therapy for Advanced Pancreatic Cancer
NCT04146298Pancreatic Cancer, Pancreatic Neoplasms, Pancreatic Ductal Adenocarcinoma, Advanced Cancer
Changhai Hospital
Phase 1/2
30
Shanghai
2021-10-21
Active, closed
A Clinical Study to Evaluate the Efficacy and Safety of SI-B001 in the Treatment of Recurrent and Metastatic HNSCC
NCT05044897Head and Neck Squamous Cell Carcinoma
Sichuan Baili Pharmaceutical Co., Ltd.
Phase 2
11
Guilin, Guiyang, Shanghai
2021-10-20
Recruiting
Umbilical Cord Stem Cells for Skin Grafts in Donor Site Wounds
NCT05984628Skin Wound, Scar, Hypertrophic
Fujian Medical University Union Hospital
Not applicable
88
Fujian
2021-10-20
Active, closed
A Study to Test BI 765179 Alone and in Combination With Ezabenlimab in Patients With Advanced Cancer (Solid Tumors) and BI 765179 in Combination With Pembrolizumab in Patients With Advanced Head and Neck Cancer
NCT04958239Neoplasms
Boehringer Ingelheim
Phase 1
151
Bengbu, Changsha, Fuzhou, Guangzhou, Wuhan
2021-10-18
Recruiting
A Phase I/IIa Study of AZD8205 Given Alone or Combined, in Participants With Advanced/Metastatic Solid Malignancies
NCT05123482Breast Cancer, Biliary Tract Carcinoma, Ovarian Cancer, Endometrial Cancer
AstraZeneca
Phase 1/2
460
Beijing, Changsha, Chongqing, Guangzhou, Kunming, Shandong
2021-10-18
Recruiting
Single-agent Capecitabine as Metronomic Chemotherapy in LAHNSCC (CMHN)
NCT05044117Head and Neck Squamous Cell Carcinoma
Sun Yat-sen University
Phase 3
220
Guangzhou
2021-10-18
Recruiting
A Study of HG381 Administered to Patients With Advanced Solid Tumors
NCT04998422Advanced Solid Tumor
HitGen Inc.
Phase 1
57
Chengdu
2021-10-18
Rows per page Showing 17101–17200 of 19052
Previous 170 171 172 173 174 Next
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Chinese investigative site. Derived from ClinicalTrials.gov. Retrieved 23 September 2026. https://priyalifescience.com/clinical-trials-china?page=172

Query this register directly
GET /api/trials?country=cn&status=recruiting&format=json Try it now →
→

Browse trials by condition

Breast Cancer (416) Advanced Solid Tumors (183) Gastric Cancer (183) Colorectal Cancer (179) Hepatocellular Carcinoma (161) Advanced Solid Tumor (159) Solid Tumor (145) Non-Small Cell Lung Cancer (144) Acute Ischemic Stroke (138) Lung Cancer (134) Pancreatic Cancer (132) Non-small Cell Lung Cancer (131) Multiple Myeloma (126) Coronary Artery Disease (111) Prostate Cancer (111)
→

Browse trials by site location

Beijing (5484) Shanghai (3827) Guangzhou (3318) Hangzhou (1812) Wuhan (1343) Chengdu (1291) Nanjing (1193) Changsha (1154) Chongqing (1056) Fuzhou (1018) Tianjin (940) Zhengzhou (921) Hefei (875) Jinan (785) Changchun (641)
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and India registers.